Stocklytics Platform
Asset logo for symbol AGIO
Agios Pharmaceuticals
AGIO67
$60.91arrow_drop_up3.14%$1.85
Asset logo for symbol AGIO
AGIO67

$60.91

arrow_drop_up3.14%

AI Deep-Learning Forecast (AGIO)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Agios Pharmaceuticals (AGIO) Stocklytics Forecast

Agios Pharmaceuticals Inc (AGIO) is a biopharmaceutical company focused on discovering and developing targeted therapies for genetically defined diseases. The company's stock price has been subject to speculation and analysis, and many investors are eager to make predictions about its future performance. While it is difficult to make accurate predictions about any stock, especially in the volatile biotech industry, there are some factors that may influence AGIO's future stock price.
One potential factor that could impact AGIO's stock price is the success of its drug pipeline. AGIO has several drugs in various stages of development, targeting diseases such as acute myeloid leukemia and solid tumors. If these drugs receive regulatory approval and demonstrate positive clinical results, it could lead to increased investor confidence and a potential boost in the company's stock price. On the other hand, if these drugs fail to meet expectations or face regulatory hurdles, it could have a negative impact on AGIO's stock price.
add Agios Pharmaceuticals  to watchlist

Keep an eye on Agios Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Agios Pharmaceuticals (AGIO) stock?

Analysts have set a target price of $51.46 for Agios Pharmaceuticals (AGIO), based on forecasts from 24 analysts. The predicted price range extends from a high of $98 to a low of $28. This represents a potential increase of up to 60.87% and a decrease of -54.04% from the current price of $60.92. These forecasts are as of 2021 Jul 30.
help

What are the analyst ratings for Agios Pharmaceuticals (AGIO) stock?

The analyst ratings for Agios Pharmaceuticals (AGIO) are distributed as follows: 9 analysts recommend buying, 2 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 11 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Agios Pharmaceuticals .
help

What is the AI price prediction for Agios Pharmaceuticals (AGIO) stock?

At present, there is no AI or machine-learning-based price prediction available for Agios Pharmaceuticals (AGIO) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level